These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7512392)

  • 1. Treatment of severe pertussis by administration of specific gamma globulin with high titers anti-toxin antibody.
    Ichimaru T; Ohara Y; Hojo M; Miyazaki S; Harano K; Totoki T
    Acta Paediatr; 1993 Dec; 82(12):1076-8. PubMed ID: 7512392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
    Zackrisson G; Taranger J; Trollfors B
    J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The longevity of the immune response to filamentous hemagglutinin and pertussis toxin in patients with pertussis in a semiclosed community.
    Tomoda T; Ogura H; Kurashige T
    J Infect Dis; 1992 Oct; 166(4):908-10. PubMed ID: 1527428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of human gamma-globulin preparations against experimental aerosol infections of mice with Bordetella pertussis.
    Imaizumi A; Suzuki Y; Sato H; Sato Y
    Vox Sang; 1985; 48(1):18-25. PubMed ID: 2578698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis encephalopathy with high cerebrospinal fluid antibody titers to pertussis toxin and filamentous hemagglutinin.
    Grant CC; McKay EJ; Simpson A; Buckley D
    Pediatrics; 1998 Oct; 102(4 Pt 1):986-90. PubMed ID: 9755273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pertussis with pertussis immune globulin.
    Balagtas RC; Nelson KE; Levin S; Gotoff SP
    J Pediatr; 1971 Aug; 79(2):203-8. PubMed ID: 4104454
    [No Abstract]   [Full Text] [Related]  

  • 8. Pertussis seroepidemiology in Taipei.
    Chiu TF; Lee CY; Lee PI; Lu CY; Lin HC; Huang LM
    J Formos Med Assoc; 2000 Mar; 99(3):224-8. PubMed ID: 10820955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB; Wilson JV; Habel H; Blaskett A
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of pertussis and pneumonia complicating pertussis; the role of hyperimmune gamma globulin and sulfadiazine.
    BRAINERD H
    J Pediatr; 1948 Jan; 32(1):30-4. PubMed ID: 18920569
    [No Abstract]   [Full Text] [Related]  

  • 12. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies to pertussis toxin in whooping cough.
    Granström M; Granström G; Gillenius P; Askelöf P
    J Infect Dis; 1985 Apr; 151(4):646-9. PubMed ID: 2857752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.
    Halperin SA; Eastwood B; Barreto L; Mills E; Blatter M; Reisinger K; Bader G; Keyserling H; Roberts EA; Guasparini R
    Scand J Infect Dis; 1995; 27(3):279-87. PubMed ID: 8539554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective role of maternally derived antibodies against Bordetella pertussis in young infants.
    Heininger U; Riffelmann M; Bär G; Rudin C; von König CH
    Pediatr Infect Dis J; 2013 Jun; 32(6):695-8. PubMed ID: 23429559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of erythromycin to prevent pertussis in newborns of mothers with pertussis.
    Granström G; Sterner G; Nord CE; Granström M
    J Infect Dis; 1987 Jun; 155(6):1210-4. PubMed ID: 2883239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A CASE OF PERTUSSIS IN ADULT THAT COULD BE DIAGNOSED BY DETECTION OF BORDETELLA PERTUSSIS FROM SPUTUM].
    Usuba A; Komase Y; Oyama B; Tsuburai T; Hida N
    Arerugi; 2017; 66(10):1230-1235. PubMed ID: 29249756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model.
    Huh DH; Han SB; Shin HJ; Ahn DH; Choi GS; Kang KR; Kim BR; Kang JH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):732-739. PubMed ID: 28720318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.